We are a coalition of doctors, researchers, patients, and entrepreneurs pioneering a new approach to curing diseases through innovative outcome-based financing. We collaborate with impact investors and payers to discover life-altering therapies and bring them to patients.
The first disease we are attacking is pancreatitis. The world’s top pancreatic experts believe a well-funded, coordinated research and development program could lead to effective treatments within 10 years. Mission: Cure is working to make that happen. Consulting with pancreatic experts from the nation’s top research and healthcare institutions, we are developing a 10-year plan.
OUR APPROACH
Financing Based On Patient Outcomes
Promising And Cost-Effective Methods To Cure Diseases
Active Collaboration Among Stakeholders
Partnerships With Impact Investors
The time is right to create a new model for curing disease. Exciting developments in genetics and data are making precision medicine a reality. Healthcare payers are moving toward value-based funding, especially for chronic diseases. And a new generation of impact investors—seeking to generate social and not just financial returns—have made curing disease a priority.
Donate
We cannot do this without your support.
News from Mission: Cure
Pancreatic Enzyme Replacement Therapy – Worldwide Expert Gives Pancreatitis Patients New Information on Treating Pancreatic Insufficiency
Busting the Myths about Pancreatic Enzymes for Pancreatitis Dr. Steven Freedman, MD, Ph.D., a worldwide expert on pancreatic disease and cystic fibrosis, presents Busting the Myths about Pancreatic Enzymes for Pancreatitis. In this webinar, the fifth in Mission: Cure’s Patient and Family Webinar Series, Dr. Freedman explains: What causes exocrine pancreatic insufficiency (EPI)? How is EPI diagnosed and treated? When should you…
Read More Potential Chronic Pancreatitis Treatments Identified
On February 28, 2019, Rare Disease Day, an alliance of leading life-science companies, in partnership with Mission: Cure, announced the promising results of a 4-month "datathon" aimed at identifying potential treatments for chronic pancreatitis. Using artificial intelligence and statistical techniques, datathon participants identified 4 existing, approved drugs as repurposing candidates worth testing as possible cures for pancreatitis. New Pancreatitis Treatment…
Read More Mission: Cure – Blog
Genetic Testing for Pancreatitis: What We Know Now
Dr. Mark Haupt, MD is the Chief Medical Officer of Ariel Precision Medicine, a company that provides digital health and genomics solutions for complex disorders, like pancreatitis. Dr. Haupt is a Pediatric Pulmonologist who has dedicated his career to helping patients with pancreatic disease through his work in academia, the pharmaceutical industry, and his current work with Ariel. As a…
Read More Kayla-Ann Keagy: Courage Award Recipient Tells Her Story
At the 2018 LA Party for a Cure fundraising event, Mission: Cure had the honor of awarding the Courage Award to four remarkable young individuals living with chronic pancreatitis. While the event as a whole was a verifiable success, raising over $150,000 to support the search for a cure, it was the stories of Matthew Musto (aka blackbear), Kayla-Ann Keagy,…
Read More